Opioid Addiction Prevention Act of 2017
Latest action · Dec 13, 2017 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedNov 15, 2017
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Opioid Addiction Prevention Act of 2017
This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law.
An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.
Cosponsors 1
Members who signed on, in the order they did. All signed on Nov 15, 2017.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Thomas R. Suozzi | Original | Nov 15, 2017 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Nov 15, 2017 |
| Health Subcommittee | Referred Nov 17, 2017 | |
| House | Judiciary Committee | Referred Nov 15, 2017 |
| Crime and Federal Government Surveillance Subcommittee | Referred Dec 13, 2017 |
Actions 4
Everything that happened, newest first.
- Dec 13, 2017Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Nov 17, 2017Referred to the Subcommittee on Health.
- Nov 15, 2017Introduced in House
- Nov 15, 2017Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 163, no. 187, November 15, 2017, page H9377.
Related bills 4
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 892 | Opioid Addiction Prevention Act of 2017 | Identical bill | Apr 7, 2017 |
| HR 1614 | John S. McCain Opioid Addiction Prevention Act | Reintroduced Bill | Apr 12, 2019 |
| HR 3964 | Opioid Addiction Prevention Act of 2017 | Related bill | Oct 16, 2017 |
| HR 4482 | Opioid Abuse Deterrence, Research, and Recovery Act of 2017 | Related bill | Jan 9, 2018 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.
- Short Titles as Introduced
- Opioid Addiction Prevention Act of 2017
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- Nov 15, 2017Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.